Fatal Guillain-Barre Syndrome
Neurol 52:635-638, Lawn,N.D.&Wijdicks,E.F.M., 1999
Guillain-Barre Syndrome
NEJM 366:2294-2304, Yuki, N. & Hartung, H.P., 2012
Guillain-Barre Syndrome
Lancet 366:1653-1666, Hughes,R.C. &Comblath,D.R., 2005
Prognostic Factors of Guillain-Barre Syndrome After Intravenous Immunoglobulin or Plasma Exchange?
Neurol 53:598-604, Visser,L.H.,et al, 1999
Campylobacter Jejuni Infection and Anti-GM1 Antibodies in Guillain-Barre Syndrome
Ann Neurol 40:181-187, Jacobs,B.C.,et al, 1996
Campylobacter Jejuni Infection and Guillain-Barre Syndrome
NEJM 333:1374-1379, 14151995., Rees,J.H.,et al, 1995
Serum Antibodies to GM1, GD1b, Peripheral Nerve Myelin, & C. Jejuni in Pts with Guillain-Barre Synd & Controls
Ann Neurol 34:130-135, Vriesendorp,F.J.,et al, 1993
Intensive Management and Treatment of Severe Guillain-Barre Syndrome
Crit Care Med 21:433-446, Hund,E.F.,et al, 1993
The Guillain-Barre Syndrome
NEJM 326:1130-1136, Ropper,A.H., 1992
A Prospective Study of Acute Idiopathic Neuropathy, I, Clinical Features & Their Prognostic Value
JNNP 51:605-612, Winer,J.B.,et al, 1988